weight loss medication semaglutide (wegovy) for GLP-1 Weight Loss Medication -

I probably don't even need to tell you how Melanotan and Melatonin are two completely different things

Cell (2024)

gastric ulcers, duodenal ulcers, and mucosal erosion where direct local peptide delivery to the damaged tissue is the therapeutic goal Inflammatory bowel conditions: Crohn's disease and ulcerative colitis support, where VEGF-mediated mucosal angiogenesis and anti-inflammatory effects have been investigated Leaky gut and intestinal hyperpermeability: tight junction restoration and mucosal integrity support in patients with compromised gut barrier function Gastroparesis: pro-motility effects via vagal cholinergic pathways investigated in preclinical models of delayed gastric emptying

Notoriously, both GIPR agonists and antagonists lead to weight loss mainly when co-administrated with GLP-1 agonists or analogues (Killion et al